TMAO levels are elevated in T2D and predictive of future diabetes [60], and markedly suppressing its formation through genetic or pharmacological inhibition of the hepatic FMO3 enzyme has been proposed to improve insulin secretion and glycemic control in diabetic mice [59]. This evidence concerns the gene INS and diabetes mellitus.